Insights
Insights on health, access and innovation
Read practical thinking from Newmarket Strategy on the policy, access, reimbursement and health system issues shaping healthcare and life sciences.
NICE’s Changing Role: a win for NICE, if it can deliver
First in a series of articles considering the implications of NICE’s changing role for industry and patients. NICE’s role and remit has grown and morphed over its twenty plus year history,…
Same challenges, new opportunities – the impact for industry of the Commercial Framework for New Medicines
As any experienced market access professional will tell you, securing access to a new medicine is rarely as simple as just submitting a dossier to a national body and waiting for a positive recommendation. Behind the…
Bringing in Change with Brexit
There is no doubting the importance of the Brexit trade deal, given how closely linked the EU and the UK markets are. There are enormous numbers involved; every month at least 45 million packs of medicines are…
Introducing Newmarket Strategy – a new consultancy specialising in healthcare innovation
Today sees the launch of Newmarket Strategy, a strategic and technical advisory business specialising in healthcare and life sciences. This new venture brings together three existing companies whose leaders have decades of experience in…
Events
